Skip to main content
Terug
Watch Compare

AVAI BIO, INC.

AVAI
OTC Technology Cloud & Data Services
€ 0,31
▲ € 0,02 (6,94%)
Marktkapitalisatie: 42,58 M
Prijs
€ 0,31
Marktkapitalisatie
42,58 M
Dagbereik
€ 0,31 — € 0,34
52-Weeksbereik
€ 0,26 — € 0,83
Volume
61.518
Openen € 0,32
50D / 200D Gem.
€ 0,41
24,55% below
50D / 200D Gem.
€ 0,43
28,49% below

Koershistorie

Financiële Trends

No fundamental snapshot available yet.

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Revenue 276.324,0
Net Income -1,14 M -2,13 M -126.521,0 -248.022,0 -69.593,0
EPS (Diluted)
Gross Profit -40.453,0 210.794,0 16.536,0 256.334,0
Operating Income -1,14 M -2,13 M 126.521,0 248.022,0 -69.593,0
EBITDA
R&D Expenses 27.040,0
SG&A Expenses
D&A 74.320,0 76.953,0 39.102,0
Interest Expense 921.306,0 1,21 M
Income Tax

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Total Assets 224.745,0 322.014,0 454.664,0 868.680,0 419.971,0
Total Liabilities 1,79 M 1,79 M 860.225,0
Shareholders' Equity -1,56 M -1,47 M -405.561,0 -275.002,0 -37.686,0
Total Debt
Cash & Equivalents 81.053,0 281,0 33.289,0 60.364,0 27.301,0
Current Assets 93.133,0 116.082,0 330.872,0 672.704,0 148.363,0
Current Liabilities 1,79 M 1,79 M 860.225,0 1,14 M 419.971,0